Beauparlant,Pierre

Institution: Gemin X Pharmaceuticals Canada Inc., 3576 Avenue du Parc, Suite 4310, Montréal, Québec, Canada

Research Interests: Animals, Cancer, Cancers, Cell, Cell Death, Cell Lines, Cells, Death, Glioblastomas, Human, Inhibition, mRNA, Nad, Neuroblastomas, Nicotinamide, Nicotinamide Phosphoribosyltransferase, Nicotinic Acid, Permits, Phase I Clinical Trials, Production